InspireMD, Inc.
NSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $110,271 | $68,193 | $6,770 | $22,185 |
| - Cash | $18,916 | $9,640 | $4,632 | $12,004 |
| + Debt | $2,338 | $1,595 | $1,614 | $1,201 |
| Enterprise Value | $93,693 | $60,148 | $3,752 | $11,382 |
| Revenue | $7,009 | $6,205 | $5,171 | $4,495 |
| % Growth | 13% | 20% | 15% | – |
| Gross Profit | $1,506 | $1,807 | $1,117 | $754 |
| % Margin | 21.5% | 29.1% | 21.6% | 16.8% |
| EBITDA | -$33,223 | -$20,911 | -$18,525 | -$14,555 |
| % Margin | -474% | -337% | -358.2% | -323.8% |
| Net Income | -$32,005 | -$19,916 | -$18,491 | -$14,918 |
| % Margin | -456.6% | -321% | -357.6% | -331.9% |
| EPS Diluted | -0.76 | -0.82 | -2.35 | -2.03 |
| % Growth | 7.3% | 65.1% | -15.8% | – |
| Operating Cash Flow | -$21,868 | -$16,376 | -$15,542 | -$13,210 |
| Capital Expenditures | -$1,402 | -$381 | -$473 | -$344 |
| Free Cash Flow | -$23,270 | -$16,757 | -$16,015 | -$13,554 |